Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
John BusbyÚ McMenaminA SpenceB T JohnstonC HughesC R CardwellPublished in: Alimentary pharmacology & therapeutics (2017)
In this large population-based gastro-oesophageal cancer cohort, we found moderately reduced cancer-specific mortality among ARB users. However, confirmation in further independent epidemiological studies with sufficient staging information is required.